Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction. Landras A, Reger de Moura C, Villoutreix BO, Battistella M, et al. Oncogene 2022 Feb 26. pii: 10.1038/s41388-022-02244.

Read + Share

Amedeo Smart

Independent Medical Education

Landras A, Reger de Moura C, Villoutreix BO, Battistella M, et al. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction. Oncogene 2022 Feb 26. pii: 10.1038/s41388-022-02244.
PMID: 35217792